ESR1 and breast carcinoma: In order to test if PR is regulated by miRNAs in-vivo, we analyzed expression levels of PR mRNA, miR-181a, miR-23a and miR-26b in samples from 29 ER positive, HER2 negative breast cancer patients (see Table 1).